Keywords
computed tomography
clinical presentation
stroke mimics
diagnosis
Kinshasa
How to Cite
Abstract
Introduction
Stroke is a leading cause of mortality and long-term disability worldwide, particularly in low- and middle-income countries. Accurate differentiation between ischaemic stroke, haemorrhagic stroke, and stroke mimics is essential for appropriate management. In resource-limited settings, non-contrast brain computed tomography (CT) remains the primary imaging modality for confirming the diagnosis and guiding treatment decisions.
Purpose
To describe the clinical and brain CT characteristics of patients with suspected stroke and assess the association between clinical findings and CT-confirmed stroke at the University Clinics of Kinshasa.
Methods
A hospital-based descriptive and analytical cross-sectional study was conducted at the University Clinics of Kinshasa, Democratic Republic of the Congo, from January to June 2024. All eligible patients referred for brain CT because of clinically suspected stroke were consecutively enrolled. Sociodemographic, clinical, and comorbidity data were collected from medical records. Brain CT findings were classified as ischaemic stroke, haemorrhagic stroke, normal findings, or stroke mimics. Data were analysed using Stata/MP 17.0. Logistic regression was used to identify factors associated with CT-confirmed stroke.
Results
A total of 567 patients were included, with a mean age of 61.5 ± 14.2 years; 52.9% were male. Brain CT confirmed stroke in 336 patients (59.3%), while 81 (14.3%) had normal CT findings and 150 (26.4%) had stroke mimics. Among CT-confirmed strokes, 261 (77.7%) were ischemic and 75 (22.3%) were hemorrhagic. The most common clinical manifestations were limb motor deficit (64.4%), altered consciousness (58.7%), and headache (23.5%), whereas hypertension (81.7%) was the predominant comorbidity. In multivariable analysis, limb motor deficit (aOR = 1.73, 95% CI: 1.17–2.56; p = .006), language impairment (aOR = 2.52, 95% CI: 1.19–5.33; p = .016), and hypertension (aOR = 2.20, 95% CI: 1.41–3.43; p < .001) were independently associated with CT-confirmed stroke, whereas age ≥65 years was associated with lower odds of CT-confirmed stroke (aOR = 0.50, 95% CI: 0.33–0.75; p < .001).
Conclusion
Approximately two-fifths of patients clinically suspected of stroke did not have CT-confirmed stroke, highlighting the limitations of clinical assessment alone. Ischaemic stroke was the predominant subtype, and specific clinical features were significantly associated with CT-confirmed stroke. These findings reinforce the importance of brain CT for accurate diagnosis and differentiation of stroke subtypes in resource-limited settings.
References
Abadi, T., Teklu, T., Wondmagegn, T., Alem, M., & Desalegn, G. (2025). Helicobacter pylori infection and associated risk factors among HIV-positive and HIV-negative individuals in Northern Ethiopia. Journal of Infection and Chemotherapy, 31(2). https://doi.org/10.1016/j.jiac.2024.09.006
Ali, M., Salaou, C., Lamine Hadja Zarra, E., Adamou, F., Moustapha, A., Ibrahim, A., O Eric, A., Sangare, L., & UFR/SDS Université Joseph KI-ZERBO. (2024). Prévalence de l’infection à Helicobacter pylori en Afrique: Une revue documentaire (2010 à 2022). Journal Africain des Cas Cliniques et Revues, 8(3), 378–391. https://doi.org/10.70065/24JA83.010L023009
Baryshnikova, N. V., Ermolenko, E. I., Leontieva, G. F., Uspenskiy, Y. P., & Suvorov, A. N. (2024). Helicobacter pylori infection and metabolic syndrome. Exploration of Digestive Diseases, 3, 414–427. https://doi.org/10.37349/edd.2024.00058
Bhan, M. K., Bahl, R., Sazawal, S., Sinha, A., Kumar, R., Mahalanabis, D., & Clemens, J. D. (2002). Association between Helicobacter pylori infection and increased risk of typhoid fever. The Journal of Infectious Diseases, 186(12), 1857–1860. https://doi.org/10.1086/345762
Bisingurege Kagoro, F., Tsongo Kibendelwa, Z., Batina Agasa, S., Bafwa, Y., Mobali Wilonja Célestin, C., Chelo Ngadjole Herman, H., Kpane Chunga, F., & Ruhemura, J. (2024). Infection à Helicobacter pylori: Aspect epidémio-clinique et facteurs associés dans la ville de Bunia et commune de Mahagi. Kivu Medical Journal, 2(2), 1–9.
Bouchentouf, R. (2012). Respiratory pathologies due to gastro-esophageal reflux (Pathologies respiratoires liées au reflux gastro-œsophagien). Journal of Functional Ventilation and Pulmonology, 3(6), 4–7.https://doi.org/10.12699/jfvp.3.6.2012.4
Charan, J., & Biswas, T. (2013). How to calculate sample size for different study designs in medical research? Indian Journal of Psychological Medicine, 35(2), 121–126. https://doi.org/10.4103/0253-7176.116232
Chen, Y., You, N., Yang, C., & Zhang, J. (2023). Helicobacter pylori infection increases the risk of carotid plaque formation: Clinical samples combined with bioinformatics analysis. Heliyon, 9(9), e20037. https://doi.org/10.1016/j.heliyon.2023.e20037
Drubay, D. (n.d.). Analyse de la relation dose-réponse pour les risques de mortalité par cancer et par maladie de l’appareil circulatoire chez les mineurs d’uranium [Unpublished Report].
Eisa, S. Y., Ahmed, K. Y., & El Sayed, W. E. (2020). The relationship between Helicobacter pylori infection and control of type 2 diabetes mellitus. The Scientific Journal of Al-Azhar Medical Faculty, Girls, 4(3), 388–393. https://doi.org/10.4103/sjamf.sjamf_50_20
Fakhry, S. M., Kandyl, M. A.-H., Hashish, A. F., Kandeel, W., El-Shenawy, A. M., El-Sayed, H. S., Dewidar, M. K., Badr, S. M., & Mehanna, N. S. (2023). Can probiotics play a role in Helicobacter pylori (H. pylori) eradication? Egyptian Liver Journal, 13(1), 64. https://doi.org/10.1186/s43066-023-00294-4
Franceschi, F., Gasbarrini, A., Polyzos, S. A., & Kountouras, J. (2015). Extragastric diseases and Helicobacter pylori. Helicobacter, 20(S1), 40–46. https://doi.org/10.1111/hel.12256
Gravina, A. G., Priadko, K., Ciamarra, P., Granata, L., Facchiano, A., Miranda, A., Dallio, M., Federico, A., & Romano, M. (2020). Extra-gastric manifestations of Helicobacter pylori infection. Journal of Clinical Medicine, 9(12), 3887. https://doi.org/10.3390/jcm9123887
He, M., Zheng, Y., Ma, A., Zhang, C., Yu, Y., Wang, H., Chen, Y., Xiang, M., Tao, K., & Shen, J. (2020). Helicobacter pylori is associated with weakened pulmonary function and reduced incidence of allergic conditions in patients with chronic cough. Experimental and Therapeutic Medicine, 20(5), 47. https://doi.org/10.3892/etm.2020.9176
Kouitcheu Mabeku, L. B., Noundjeu Ngamga, M. L., & Leundji, H. (2020). Helicobacter pylori infection, a risk factor for Type 2 diabetes mellitus: A hospital-based cross-sectional study among dyspeptic patients in Douala-Cameroon. Scientific Reports, 10(1), 12141. https://doi.org/10.1038/s41598-020-69208-3
Kpossou, A. R., Kouwakanou, H. B., Ahouada, C., Vignon, R. K., Martin Sokpon, C. N., Zoundjiekpon, V., Kodjoh, N., & Séhonou, J. (2021). Infection par Helicobacter pylori: Prévalence et facteurs associés dans une population tout venant d'après une recherche par test respiratoire à l'urée marquée au carbone 14. Pan African Medical Journal, 40. https://doi.org/10.11604/pamj.2021.40.266.22378
Kyolo, S. K., Bbosa, G. S., Odda, J., Lubega, A. M., & Edmond, N. N. (2018). Toxicity profile of karuho poison on the brain of Wistar albino rats. Neuroscience and Medicine, 9(2), 63–80. https://doi.org/10.4236/nm.2018.92008
Kyolo, S. K., Odda, J., Lubega, A., & Bbosa, G. S. (2019). Blood chemistry and major body organ induced-toxicity by locally-made traditional OMGKRP karuho poison in Wistar albino rats. Neuroscience and Medicine, 10(3), 272–291. https://doi.org/10.4236/nm.2019.103021
Leloutre, B. (2024). L’inflammation systémique de bas grade, un nouveau paradigme à explorer. Hegel, 2(2), 97–109. https://doi.org/10.3917/heg.142.0097
Loosen, S. H., Mertens, A., Klein, I., Leyh, C., Krieg, S., Kandler, J., Luedde, T., Roderburg, C., & Kostev, K. (2024). Association between Helicobacter pylori and its eradication and the development of cancer. BMJ Open Gastroenterology, 11(1), e001377. https://doi.org/10.1136/bmjgast-2024-001377
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O’Morain, C., Rugge, M., Suerbaum, S., Tilg, H., Sugano, K., & El-Omar, E. M. (2022). Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut, 71(9), 1724–1762. https://doi.org/10.1136/gutjnl-2022-327745
Mansori, K., Moradi, Y., Naderpour, S., Rashti, R., Moghaddam, A. B., Saed, L., & Mohammadi, H. (2019). Association of Helicobacter pylori infection with diabetes mellitus: A meta-analysis of case control studies [Preprint]. In Review. https://doi.org/10.21203/rs.2.18464/v1
Mansori, K., Moradi, Y., Naderpour, S., Rashti, R., Moghaddam, A. B., Saed, L., & Mohammadi, H. (2020). Helicobacter pylori infection as a risk factor for diabetes: A meta-analysis of case-control studies. BMC Gastroenterology, 20(1), 77. https://doi.org/10.1186/s12876-020-01223-0
Marcellini, A., Turpin, J.-P., Rolland, Y., & Ruffié, S. (2000). Itinéraires thérapeutiques dans la société contemporaine: Le recours aux thérapies alternatives: une éducation à un « autre corps »? Corps et Culture, (5). https://doi.org/10.4000/corpsetculture.710
Mazzoleni, L. E. (2011). Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Archives of Internal Medicine, 171(21), 1929. https://doi.org/10.1001/archinternmed.2011.533
Mbeva, J.-B. K., Prudence, M. N., Musubao, E. T., Nzanzu, My., Namegabe, N., Kimanuka, C., Lambert, H., & Porignon, D. (2021). Itinéraire thérapeutique du patient en milieu urbain africain: Cas de la ville de Goma à l’est de la RD Congo. International Journal of Innovation and Scientific Research, 53(1), 85–97. http://www.ijisr.issr-journals.org/
Mwabi, A. N., Ntakarutimana, V., & Bisimwa, G. B. (2020). Poisoning investigations in the city of Bukavu and the effects of antidotes administered by traditional healers. International Journal of Innovative Science and Research Technology, 5(2). https://www.ijisrt.com
Nassenstein, N. (2019). The linguistic taboo of poisoning in Kivu Swahili. Academia. https://www.academia.edu/39209581/The_linguistic_taboo_of_poisoning_in_Kivu_Swahili
Ndelo Di Phanzu, J., Mputu Malolo, L.-C., Ndelo Matondo, P., & Belo Nuapia, Y. (2024). Atmospheric pollution and toxicological aspects of Helicobacter pylori infection: Background, pathophysiology and new innovative hypotheses. In D. C. Lazar (Ed.), Gastric cancer—Progress and challenges in the era of precision medicine. IntechOpen. https://doi.org/10.5772/intechopen.1005009
Park, S. K. (2016). Extra-digestive manifestations of Helicobacter pylori infection – An overview. In Extradigestive manifestations of Helicobacter pylori infection—An overview. IntechOpen. https://doi.org/10.5772/63226
Silva, C. S., da Silva Júnior, R. T., de Sá Santos, L. K., Apolonio, J. S., da Costa, BT., Cuzzuol, B. R., et al. (2021). Extragastric manifestations of Helicobacter pylori infection: A commentary. Archives of Gastroenterology Research, 2(3), 102–109. https://doi.org/10.33696/Gastroenterology.2.035
Song, X., Cai, C., Jin, Q., Chen, X., & Yu, C. (2021). The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta‐analysis. Helicobacter, 26(2), e12781. https://doi.org/10.1111/hel.12781
Sun, L., Zheng, H., Qiu, M., Hao, S., Liu, X., Zhu, X., Cai, X., & Huang, Y. (2023). Helicobacter pylori infection and risk of cardiovascular disease. Helicobacter, 28(3), e12967. https://doi.org/10.1111/hel.12967
Tali, L. D. N., Faujo, G. F. N., Konang, J. L. N., Dzoyem, J. P., & Kouitcheu, L. B. M. (2022). Relationship between active Helicobacter pylori infection and risk factors of cardiovascular diseases, a cross-sectional hospital-based study in a Sub-Saharan setting. BMC Infectious Diseases, 22(1), 731. https://doi.org/10.1186/s12879-022-07718-3
Vollaard, A. M., Verspaget, H. W., Ali, S., Visser, L. G., Veenendaal, R. A., Van Asten, H. A. G. H., Widjaja, S., Surjadi, C., & Van Dissel, J. T. (2006). Helicobacter pylori infection and typhoid fever in Jakarta, Indonesia. Epidemiology and Infection, 134(1), 163–170. https://doi.org/10.1017/S0950268805004875
Wang, L., Cao, Z.-M., Zhang, L.-L., Dai, X.-C., Liu, Z.-j., Zeng, Y.-x., Li, X.-y., Wu, Q.-j., & Lv, W.-l. (2022). Helicobacter pylori and autoimmune diseases: Involving multiple systems. Frontiers in Immunology, 13, 833424. https://doi.org/10.3389/fimmu.2022.833424
Wei, B.-R., Zhao, Y.-J., Cheng, Y.-F., Huang, C., & Zhang, F. (2024). Helicobacter pylori infection and Parkinson’s disease: Etiology, pathogenesis and levodopa bioavailability. Immunity & Ageing, 21(1), 1. https://doi.org/10.1186/s12979-023-00404-1
Wizenty, J., Koop, P.-H., Clusmann, J., Tacke, F., Trautwein, C., Schneider, K. M., Sigal, M., & Schneider, C. V. (2023). Association of Helicobacter pylori positivity with risk of disease and mortality. Clinical and Translational Gastroenterology, 14(9), e00610. https://doi.org/10.14309/ctg.0000000000000610
Wondmagegn, Y. M., Girmay, G., Amare, G. A., Assefa, M., Tamir, M., Abriham, Z. Y., & Setegn, A. (2025). Prevalence of intestinal parasites and Helicobacter pylori co-infection in people with gastrointestinal symptoms in Africa: A systematic review and meta-analysis. BMC Infectious Diseases, 25(1), 20. https://doi.org/10.1186/s12879-024-10432-x
Yadav, S., Singh, P., & Singh, N. (2024). Helicobacter pylori infection: The extragastric manifestations - A review. International Journal of Health Sciences and Research, 14(7), 145–153. https://doi.org/10.52403/ijhsr.20240718
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2026 Mbutiwi, T. L., Lelo, M. T., Yanda, S. T., Mukaya, J. T., Makwanza, L. K., Mazoba, T. K., Mbutiwi, F. I. N., Molua, A. A.